Rare diseases
Investigational molecules
Locations
Back to Belgium16 clinical trials in Pelt, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on relapsing forms of multiple sclerosis, evaluating novel therapeutic approaches and comparing treatment efficacies. Studies investigate various medications including frexalimab and remibrutinib against established treatments.
Several trials aim to assess reduction in relapse frequency and improvement in patient outcomes.
Dedicated research into primary progressive multiple sclerosis (PPMS) and secondary progressive forms, exploring innovative treatments and their impact on disease progression. Studies evaluate higher-dose protocols and long-term effectiveness.
Focus on developing treatments to delay disability progression and improve patient mobility.
Investigation of innovative treatment modalities including BTK inhibitors and combination therapies. Research includes assessment of brain remyelination and neurodegeneration markers.
Comprehensive evaluation of new therapeutic approaches using advanced imaging and clinical assessments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
